Adaptimmune Therapeutics (ADAP) Stock Price, Quote & News

Adaptimmune Therapeutics (ADAP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.58

-0.38%

After-hours Dec 13, 2024, 07:03 PM EST

undefined% (undefined)

Bid	0.58
Market Cap	150.08M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.17
PE Ratio (ttm)	-3.45
Forward PE	n/a
Shares Out	255.88M
Short % of Shares Out	undefined%

Ask	0.59
Volume	2,981,693
Open	0.60
Previous Close	0.63
Day's Range	0.55 - 0.62
52-Week Range	0.43 - 2.05
Beta	undefined
Shares Float	-
Short % of Float	undefined%

About ADAP

undefined

[Show more]

Industry -

Sector -

IPO Date n/a

Employees NaN

Stock Exchange -

Ticker Symbol ADAP

Website -

Analyst Forecast

According to 0 analyst ratings, the average rating for ADAP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Buy 0%

Hold 0%

Sell 0%

Stock Forecasts

Why Price Moved

News

No News article available yet